RxDoctor Payments Data

John Um, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Omaha, NENPI 1134346745

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (38.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Abbott at 53.0% of the total. Reporting peaked in 2019 at $7,619 and has fallen 79.0% since, to $1,602 in 2025.

$16,441in general payments, 2019–2025

Across 102 payments — averaging $161.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$9K
  • Medtronic$5K
  • Abiomed$2K
  • Edwards Lifesciences$610
  • Bayer$125
  • Livanova USA, Inc.$121
  • plus $88 from 2 others
$286,675in research payments, 2019–2025

Across 66 payments — averaging $4343.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$179K
  • Transmedics, Inc.$108K

What the payments were for

  • Consulting fees$5,20032%
  • Travel & lodging$4,96030%
  • Food & beverage$6,28138%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,441 in reported general payments places this provider in the 75th percentile of 29 thoracic surgery (cardiothoracic vascular surgery) providers in Nebraska.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Nebraska

Medicare billing

Part B allowed, 2024
$104,291
Medicare patients
49
Services billed
153

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →